Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischemic cardiomyopathy.

@article{Alan2003LongtermGI,
  title={Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischemic cardiomyopathy.},
  author={Sait Alan and Mehmet Siddik Ulgen and I. Ozhan Dedeoglu and Halil Kaya and Nizamettin Arat Toprak},
  journal={Swiss medical weekly},
  year={2003},
  volume={133 29-30},
  pages={419-22}
}
UNLABELLED We assessed the effects of glucose-insulin-potassium (GIK) using echocardiography, right ventricular catheterisation and myocardial scintigraphy with 99mTc sestamibi in stable patients with ischaemic cardiac dysfunction. METHODS Thirty male patients with stable coronary disease (SCD) and an ejection fraction (EF) <40% were studied for systolic and diastolic function. Glucose 30%, 300 insulin units and KCl 6 g/l were infused at 1 ml/kg per hour for 24 hours. Haemodynamic… CONTINUE READING